Apr 23, 2024, 15:39 by Molly McGrath

ASAM submitted a written statement for the record to the the U.S. Senate Committee on Finance, Subcommittee on Health Care, which held a roundtable discussion on April 9th, Closing Gaps in the Care Continuum: Opportunities to Improve Substance Use Disorder Care in the Federal Health Programs, and discussed barriers to methadone treatment for opioid use disorder.

Apr 23, 2024, 15:03 by ASAM Weekly Editors

Preventing deaths after prison release

Apr 18, 2024, 10:45 by Kelly Corredor

Apr 17, 2024, 09:29 by ASAM Weekly Editors

Telling the story of the opioid crisis: A narrative analysis of the TV series Dopesick

Apr 9, 2024, 17:09 by Kelly Corredor

Apr 9, 2024, 14:56 by ASAM Weekly Editors

Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration

Apr 9, 2024, 14:38 by Molly McGrath

On April 9th, the Colorado Society of Addiction Medicine (COSAM) sent a letter to members of the Senate Committee on Finance in support of SB24-181.

Apr 9, 2024, 14:21 by Molly McGrath

On April 7th, the Georgia Society of Addiction Medicine (GSAM) sent a letter to the Georgia Composite Medical Board (GCMB) urging them to extend flexibilities for prescribing medications for addiction via telehealth.

Apr 9, 2024, 10:03 by Molly McGrath

ASAM's public policy statement on Medical Ethics in Addiction Medicine offers practical guidance to addiction specialist physicians and can apply to any physician or healthcare professional engaged in addiction treatment.

Apr 3, 2024, 09:46 by ASAM Weekly Editors

Epigenome-wide association study on methamphetamine dependence.

Apr 2, 2024, 12:52 by Molly McGrath

On April 1, over 80 organizations sent a letter to the Chair and Ranking Member of the House and Senate Appropriations Subcommittees on Labor, Health and Human Services, Education, and Related Agencies.

Mar 26, 2024, 15:14 by ASAM Weekly Editors

Disposable E-Cigarette Use and Subsequent Use Patterns in Adolescents and Young Adults

Mar 25, 2024, 00:00 by Molly McGrath

Mar 21, 2024, 13:21 by Kelly Corredor

On March 21, 2024, ASAM joined more than 120 organizations in a statement urging the Biden Administration to finalize federal rules to eliminate menthol cigarettes and flavored cigars.

Mar 20, 2024, 12:57 by Molly McGrath

On March 15th, a diverse array of nearly 100 stakeholders dedicating to enhancing access to high-quality addiction care wrote a letter calling on the 118th Congress to pass critical addiction and mental health policies.

Mar 20, 2024, 10:21 by ASAM Weekly Editors

THE ASAM CRITERIA FOURTH EDITION.

Mar 19, 2024, 14:16 by Kenneth Minkoff, MD

As an addiction psychiatrist and community psychiatrist I have worked on improving integrated systems and services for 40 years. Most recently, I helped to develop the updated standards in the 4th Edition of The ASAM Criteria that encourage all addiction treatment programs to be co-occurring capable, at minimum. (See Chapter 12: Integrating Care for Co-occurring Mental Health Conditions.)

Mar 13, 2024, 19:08 by Molly McGrath

Among other organizations urging Congress address the glaring shortage of physicians trained to treat patients with addiction, ASAM signed a letter supporting the Substance Use Disorder (SUD) Workforce Act of 2024, bipartisan legislation that provides Medicare support for an additional 1,000 new graduate medical education (GME) positions that would be implemented in hospitals accredited residency programs in addiction medicine, addiction psychiatry, or pain medicine, and their prerequisite programs, including hospitals that are establishing such programs.

Mar 12, 2024, 15:10 by ASAM Weekly Editors

Association of Cannabis Use With Cardiovascular Outcomes Among US Adults

Mar 9, 2024, 13:39 by Molly McGrath

Today, the American Society of Addiction Medicine (ASAM) applauded Congress for including important Medicaid measures supporting addiction treatment in its first Fiscal Year 2024 minibus package. Signed today by President Biden, the Consolidated Appropriations Act, 2024, will enhance Americans’ access to evidence-based addiction treatment at a time when overdose deaths are near record highs.